Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for PCVX
| Stock Name | Vaxcyte Inc |
| Ticker | PCVX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US92243G1085 |
| LEI | 254900M7NMHTGASX8D95 |
Show aggregate PCVX holdings
News associated with PCVX
- Vaxcyte, Inc. (NASDAQ:PCVX) Receives $106.25 Average Price Target from Analysts
- Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has received an average rating of “Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The […] - 2025-09-16 02:32:42
- Swiss National Bank Has $8.21 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)
- Swiss National Bank reduced its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 0.8% in the 1st quarter, HoldingsChannel reports. The fund owned 217,300 shares of the company’s stock after selling 1,700 shares during the period. Swiss National Bank’s holdings in Vaxcyte were worth $8,205,000 at the end of the most recent quarter. Several […] - 2025-08-17 05:55:01
- Natixis Advisors LLC Decreases Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
- Natixis Advisors LLC lowered its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 5.7% during the first quarter, Holdings Channel reports. The institutional investor owned 14,649 shares of the company’s stock after selling 888 shares during the period. Natixis Advisors LLC’s holdings in Vaxcyte were worth $553,000 at the end of the […] - 2025-08-12 04:38:46
- Analysts Forecast 12% Upside For JHML
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:29
- KLP Kapitalforvaltning AS Buys 500 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
- KLP Kapitalforvaltning AS increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 2.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,000 shares of the company’s stock after purchasing an additional 500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Vaxcyte […] - 2025-07-29 06:16:55
- Universal Beteiligungs und Servicegesellschaft mbH Buys 3,634 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
- Universal Beteiligungs und Servicegesellschaft mbH raised its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 3.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 107,317 shares of the company’s stock after buying an additional 3,634 shares during the quarter. Universal […] - 2025-07-29 05:22:57
- Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $136.50
- Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month […] - 2025-07-28 02:30:52
- New York State Common Retirement Fund Increases Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
- New York State Common Retirement Fund increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 190.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 137,440 shares of the company’s stock after purchasing an additional 90,145 shares during the quarter. New York […] - 2025-07-22 07:09:01
- Principal Financial Group Inc. Has $17.73 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
- Principal Financial Group Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 52.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 469,561 shares of the company’s stock after acquiring an additional 160,622 shares during the period. […] - 2025-07-11 05:21:08
- Calamos Advisors LLC Has $257,000 Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
- Calamos Advisors LLC decreased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 32.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 6,794 shares of the company’s stock after selling 3,201 shares during the period. Calamos Advisors LLC’s holdings in Vaxcyte were worth […] - 2025-07-08 05:46:54
- Vaxcyte, Inc. (NASDAQ:PCVX) Holdings Lowered by Allspring Global Investments Holdings LLC
- Allspring Global Investments Holdings LLC trimmed its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 43.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 335,990 shares of the company’s stock after selling 257,533 shares during the […] - 2025-07-04 05:06:38
- Analysts Set Vaxcyte, Inc. (NASDAQ:PCVX) Price Target at $136.50
- Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among […] - 2025-07-03 02:42:45
- Analyzing Vaxcyte (NASDAQ:PCVX) & Genenta Science (NASDAQ:GNTA)
- Genenta Science (NASDAQ:GNTA – Get Free Report) and Vaxcyte (NASDAQ:PCVX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Volatility & Risk Genenta Science has a beta of […] - 2025-06-13 02:32:52
- The Math Shows ESML Can Go To $48
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-05 07:20:56
- Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Rating of “Buy” from Brokerages
- Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has earned an average recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts […] - 2025-06-05 02:32:50
- Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM)
- Vaxcyte (NASDAQ:PCVX – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends. Risk and Volatility Vaxcyte has a beta of 1.27, […] - 2025-05-30 02:28:51
- Millennium Management LLC Sells 21,857 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
- Millennium Management LLC lessened its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 7.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 276,578 shares of the company’s stock after selling 21,857 shares during the quarter. Millennium Management LLC owned approximately […] - 2025-05-21 05:46:50
- Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Dimensional Fund Advisors LP
- Dimensional Fund Advisors LP increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 115.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 293,706 shares of the company’s stock after buying an additional 157,277 shares during the period. Dimensional Fund Advisors LP’s holdings in Vaxcyte were worth $24,043,000 at the end of the […] - 2025-05-07 05:22:50
- Mariner LLC Has $487,000 Position in Vaxcyte, Inc. (NASDAQ:PCVX)
- Mariner LLC boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 27.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 5,947 shares of the company’s stock after buying an additional 1,290 shares during the period. Mariner LLC’s holdings in Vaxcyte were worth $487,000 as of its most recent filing with the Securities […] - 2025-05-02 05:10:52
- Renaissance Technologies LLC Purchases Shares of 54,077 Vaxcyte, Inc. (NASDAQ:PCVX)
- Renaissance Technologies LLC acquired a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 54,077 shares of the company’s stock, valued at approximately $4,427,000. A number of other hedge funds and other institutional investors […] - 2025-04-22 05:03:18
- ILCB's Holdings Imply 27% Gain Potential
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-04 08:46:47
- Norges Bank Acquires Shares of 1,100,286 Vaxcyte, Inc. (NASDAQ:PCVX)
- Norges Bank bought a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,100,286 shares of the company’s stock, valued at approximately $90,069,000. Norges Bank owned about 0.88% of Vaxcyte at the end of the most […] - 2025-04-03 05:36:54
- Bank of America Lowers Vaxcyte (NASDAQ:PCVX) Price Target to $137.00
- Vaxcyte (NASDAQ:PCVX – Get Free Report) had its price target reduced by research analysts at Bank of America from $157.00 to $137.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price objective would suggest a potential upside of 306.65% from the […] - 2025-04-03 04:24:52
- Needham & Company LLC Has Lowered Expectations for Vaxcyte (NASDAQ:PCVX) Stock Price
- Vaxcyte (NASDAQ:PCVX – Get Free Report) had its target price lowered by investment analysts at Needham & Company LLC from $140.00 to $90.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 167.14% from the […] - 2025-04-03 04:24:52
- Monday's ETF Movers: FBT, XBI
- In trading on Monday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Corcept Therapeutics, up about 83.2% and shares of Amgen, up about 2% on the - 2025-03-31 13:11:30
- Proficio Capital Partners LLC Invests $2.92 Million in Vaxcyte, Inc. (NASDAQ:PCVX)
- Proficio Capital Partners LLC purchased a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 35,609 shares of the company’s stock, valued at approximately $2,915,000. Several other large investors have also recently added to or reduced their stakes in the company. Whipplewood Advisors […] - 2025-03-19 05:44:45
- PNC Financial Services Group Inc. Boosts Stake in Vaxcyte, Inc. (NASDAQ:PCVX)
- PNC Financial Services Group Inc. increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 18.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,076 shares of the company’s stock after acquiring an additional 1,397 shares during the period. PNC Financial Services Group Inc.’s holdings […] - 2025-03-18 05:38:57
- Victory Capital Management Inc. Has $24.85 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)
- Victory Capital Management Inc. lifted its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 19.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 303,556 shares of the company’s stock after purchasing an additional 48,516 shares during the quarter. Victory Capital Management Inc. owned […] - 2025-03-11 06:16:48
- Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $127.71
- Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the company, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […] - 2025-02-28 04:06:48
- After-Hours Earnings Report for February 25, 2025 : INTU, WDAY, ALC, CPNG, AXON, EXR, KEYS, FSLR, CART, CAVA, PCVX, PR
- The following companies are expected to report earnings after hours on 02/25/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Intuit Inc. (INTU)is reporting for the quarter ending January 31, 2025. The computer software company's consensus earnings - 2025-02-25 17:00:00
iShares MSCI World Small Cap UCITS ETF USD (Acc) PCVX holdings
| Date | Number of PCVX Shares Held | Base Market Value of PCVX Shares | Local Market Value of PCVX Shares | Change in PCVX Shares Held | Change in PCVX Base Value | Current Price per PCVX Share Held | Previous Price per PCVX Share Held |
|---|
| 2025-12-10 (Wednesday) | 85,079 | USD 3,700,086 | USD 3,700,086 | 0 | USD -106,348 | USD 43.49 | USD 44.74 |
| 2025-12-09 (Tuesday) | 85,079 | USD 3,806,434 | USD 3,806,434 | 0 | USD -122,514 | USD 44.74 | USD 46.18 |
| 2025-12-08 (Monday) | 85,079 | USD 3,928,948 | USD 3,928,948 | 0 | USD -25,524 | USD 46.18 | USD 46.48 |
| 2025-12-05 (Friday) | 85,079 | USD 3,954,472 | USD 3,954,472 | 0 | USD 34,882 | USD 46.48 | USD 46.07 |
| 2025-12-04 (Thursday) | 85,079 | USD 3,919,590 | USD 3,919,590 | 0 | USD -138,678 | USD 46.07 | USD 47.7 |
| 2025-12-03 (Wednesday) | 85,079 | USD 4,058,268 | USD 4,058,268 | 0 | USD 255,237 | USD 47.7 | USD 44.7 |
| 2025-12-02 (Tuesday) | 85,079 | USD 3,803,031 | USD 3,803,031 | 0 | USD -69,765 | USD 44.7 | USD 45.52 |
| 2025-12-01 (Monday) | 85,079 | USD 3,872,796 | USD 3,872,796 | -2,296 | USD -461,878 | USD 45.52 | USD 49.61 |
| 2025-11-28 (Friday) | 87,375 | USD 4,334,674 | USD 4,334,674 | 0 | USD -3,495 | USD 49.61 | USD 49.65 |
| 2025-11-27 (Thursday) | 87,375 | USD 4,338,169 | USD 4,338,169 | 0 | USD 0 | USD 49.65 | USD 49.65 |
| 2025-11-26 (Wednesday) | 87,375 | USD 4,338,169 | USD 4,338,169 | -164 | USD -59,790 | USD 49.65 | USD 50.24 |
| 2025-11-25 (Tuesday) | 87,539 | USD 4,397,959 | USD 4,397,959 | 0 | USD 86,663 | USD 50.24 | USD 49.25 |
| 2025-11-24 (Monday) | 87,539 | USD 4,311,296 | USD 4,311,296 | 0 | USD 128,683 | USD 49.25 | USD 47.78 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of PCVX by Blackrock for IE00BF4RFH31
Show aggregate share trades of PCVX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-12-01 | SELL | -2,296 | 46.960 | 44.510 | 44.755 | USD -102,757 | 56.36 Profit of 26,655 on sale |
| 2025-11-26 | SELL | -164 | 50.120 | 48.910 | 49.031 | USD -8,041 | 56.46 Profit of 1,219 on sale |
| 2025-11-26 | SELL | -164 | 50.120 | 48.910 | 49.031 | USD -8,041 | 56.46 Profit of 1,219 on sale |
| 2025-11-20 | BUY | 501 | | | 47.670* | | 56.61 |
| 2025-11-19 | BUY | 5,040 | | | 48.620* | | 56.65 |
| 2025-11-14 | SELL | -656 | 49.870 | 45.620 | 46.045 | USD -30,206 | 56.77 Profit of 7,036 on sale |
| 2025-10-29 | BUY | 328 | 43.520 | 45.130 | 44.969 | USD 14,750 | 57.62 |
| 2025-10-21 | BUY | 656 | 42.350 | 43.450 | 43.340 | USD 28,431 | 58.11 |
| 2025-10-07 | BUY | 328 | 41.870 | 41.975 | 41.964 | USD 13,764 | 58.38 |
| 2025-09-08 | SELL | -660 | 32.410 | 33.670 | 33.544 | USD -22,139 | 59.69 Profit of 17,258 on sale |
| 2025-08-15 | BUY | 328 | 32.700 | 32.825 | 32.813 | USD 10,763 | 59.85 |
| 2025-08-07 | BUY | 984 | 30.010 | 31.500 | 31.351 | USD 30,849 | 60.21 |
| 2025-07-29 | BUY | 328 | 34.680 | 35.930 | 35.805 | USD 11,744 | 61.20 |
| 2025-07-14 | BUY | 656 | 36.380 | 36.560 | 36.542 | USD 23,972 | 62.34 |
| 2025-06-30 | BUY | 660 | 32.510 | 33.620 | 33.509 | USD 22,116 | 63.69 |
| 2025-06-25 | BUY | 984 | 33.090 | 34.120 | 34.017 | USD 33,473 | 64.35 |
| 2025-06-20 | SELL | -165 | 32.870 | 33.710 | 33.626 | USD -5,548 | 65.01 Profit of 5,179 on sale |
| 2025-06-12 | SELL | -1,320 | 34.460 | 35.390 | 35.297 | USD -46,592 | 66.41 Profit of 41,076 on sale |
| 2025-06-02 | BUY | 495 | 35.020 | 35.040 | 35.038 | USD 17,344 | 68.38 |
| 2025-05-28 | BUY | 330 | 31.380 | 32.598 | 32.476 | USD 10,717 | 69.27 |
| 2025-05-14 | BUY | 165 | 29.420 | 30.380 | 30.284 | USD 4,997 | 72.55 |
| 2025-05-13 | BUY | 330 | 30.050 | 32.020 | 31.823 | USD 10,502 | 72.94 |
| 2025-05-07 | BUY | 495 | 29.000 | 30.040 | 29.936 | USD 14,818 | 74.51 |
| 2025-04-28 | BUY | 164 | 32.900 | 34.020 | 33.908 | USD 5,561 | 77.35 |
| 2025-04-16 | BUY | 2,145 | 29.120 | 30.390 | 30.263 | USD 64,914 | 81.33 |
| 2025-04-14 | BUY | 330 | 32.040 | 32.500 | 32.454 | USD 10,710 | 82.44 |
| 2025-04-08 | SELL | -330 | 30.200 | 33.750 | 33.395 | USD -11,020 | 84.88 Profit of 16,991 on sale |
| 2025-04-04 | SELL | -330 | 31.600 | 33.250 | 33.085 | USD -10,918 | 86.14 Profit of 17,508 on sale |
| 2025-03-28 | BUY | 1,630 | 69.460 | 71.220 | 71.044 | USD 115,802 | 88.28 |
| 2025-03-12 | SELL | -326 | 73.240 | 75.000 | 74.824 | USD -24,393 | 90.91 Profit of 5,243 on sale |
| 2025-03-04 | SELL | -326 | 70.240 | 72.365 | 72.152 | USD -23,522 | 92.50 Profit of 6,634 on sale |
| 2025-02-26 | SELL | -652 | 78.650 | 83.330 | 82.862 | USD -54,026 | 93.72 Profit of 7,081 on sale |
| 2025-02-13 | BUY | 163 | 83.840 | 86.445 | 86.184 | USD 14,048 | 95.77 |
| 2025-02-12 | BUY | 652 | 85.420 | 86.680 | 86.554 | USD 56,433 | 95.99 |
| 2025-01-27 | BUY | 163 | 90.910 | 93.000 | 92.791 | USD 15,125 | 98.46 |
| 2025-01-23 | BUY | 163 | 89.975 | 90.730 | 90.655 | USD 14,777 | 98.96 |
| 2024-12-09 | BUY | 5,868 | 92.060 | 94.600 | 94.346 | USD 553,622 | 99.82 |
| 2024-12-04 | BUY | 326 | 93.040 | 93.490 | 93.445 | USD 30,463 | 100.62 |
| 2024-12-03 | BUY | 489 | 90.370 | 93.380 | 93.079 | USD 45,516 | 100.99 |
| 2024-11-25 | BUY | 9,427 | 91.700 | 92.145 | 92.100 | USD 868,231 | 103.21 |
| 2024-11-19 | BUY | 834 | 87.080 | 88.170 | 88.061 | USD 73,443 | 106.70 |
| 2024-11-18 | BUY | 278 | 86.490 | 87.320 | 87.237 | USD 24,252 | 107.89 |
| 2024-11-12 | BUY | 556 | 99.380 | 103.300 | 102.908 | USD 57,217 | 108.42 |
| 2024-11-11 | BUY | 139 | 103.640 | 107.220 | 106.862 | USD 14,854 | 108.74 |
| 2024-11-07 | BUY | 695 | 102.700 | 106.980 | 106.552 | USD 74,054 | 109.36 |
| 2024-10-23 | BUY | 278 | 112.140 | 113.020 | 112.932 | USD 31,395 | 114.06 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of PCVX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 204,246 | 81 | 702,291 | 29.1% |
| 2025-09-18 | 247,318 | 147 | 1,182,122 | 20.9% |
| 2025-09-17 | 478,618 | 0 | 1,628,296 | 29.4% |
| 2025-09-16 | 258,632 | 0 | 784,301 | 33.0% |
| 2025-09-15 | 193,594 | 318 | 494,380 | 39.2% |
| 2025-09-12 | 262,307 | 0 | 527,659 | 49.7% |
| 2025-09-11 | 181,619 | 0 | 473,839 | 38.3% |
| 2025-09-10 | 278,938 | 6 | 810,108 | 34.4% |
| 2025-09-09 | 197,276 | 1,000 | 484,764 | 40.7% |
| 2025-09-08 | 356,154 | 300 | 666,464 | 53.4% |
| 2025-09-05 | 251,668 | 0 | 581,150 | 43.3% |
| 2025-09-04 | 288,827 | 4,175 | 579,054 | 49.9% |
| 2025-09-03 | 282,305 | 0 | 622,626 | 45.3% |
| 2025-09-02 | 220,320 | 0 | 734,357 | 30.0% |
| 2025-08-29 | 107,976 | 0 | 267,835 | 40.3% |
| 2025-08-28 | 260,554 | 0 | 594,666 | 43.8% |
| 2025-08-27 | 179,746 | 0 | 724,103 | 24.8% |
| 2025-08-26 | 114,100 | 0 | 664,628 | 17.2% |
| 2025-08-25 | 196,846 | 0 | 900,657 | 21.9% |
| 2025-08-22 | 120,850 | 0 | 342,735 | 35.3% |
| 2025-08-21 | 153,745 | 120 | 483,243 | 31.8% |
| 2025-08-20 | 118,380 | 0 | 353,360 | 33.5% |
| 2025-08-19 | 113,550 | 0 | 325,277 | 34.9% |
| 2025-08-18 | 156,869 | 0 | 446,083 | 35.2% |
| 2025-08-15 | 144,453 | 1,997 | 521,835 | 27.7% |
| 2025-08-14 | 214,706 | 0 | 564,088 | 38.1% |
| 2025-08-13 | 219,025 | 67 | 1,278,221 | 17.1% |
| 2025-08-12 | 247,228 | 89 | 705,279 | 35.1% |
| 2025-08-11 | 233,662 | 136 | 622,096 | 37.6% |
| 2025-08-08 | 117,171 | 10,841 | 1,145,858 | 10.2% |
| 2025-08-07 | 318,955 | 20,887 | 1,174,518 | 27.2% |
| 2025-08-06 | 125,483 | 0 | 261,571 | 48.0% |
| 2025-08-05 | 114,223 | 106 | 238,075 | 48.0% |
| 2025-08-04 | 100,205 | 0 | 238,748 | 42.0% |
| 2025-08-01 | 140,190 | 2,064 | 321,077 | 43.7% |
| 2025-07-31 | 128,745 | 0 | 378,867 | 34.0% |
| 2025-07-30 | 138,630 | 0 | 351,934 | 39.4% |
| 2025-07-29 | 181,456 | 445 | 398,378 | 45.5% |
| 2025-07-28 | 128,910 | 69 | 541,006 | 23.8% |
| 2025-07-25 | 143,535 | 100 | 357,219 | 40.2% |
| 2025-07-24 | 112,578 | 199 | 342,450 | 32.9% |
| 2025-07-23 | 116,822 | 100 | 187,700 | 62.2% |
| 2025-07-22 | 162,681 | 225 | 214,667 | 75.8% |
| 2025-07-21 | 255,787 | 100 | 321,419 | 79.6% |
| 2025-07-18 | 262,894 | 66 | 397,878 | 66.1% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy